Ind-Swift Laboratories Limited - Asset Resilience Ratio

Latest as of September 2025: 28.07%

Ind-Swift Laboratories Limited (INDSWFTLAB) has an Asset Resilience Ratio of 28.07% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See working capital to net assets of Ind-Swift Laboratories Limited to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

Rs4.33 Billion

≈ $46.88 Million USD Cash + Short-term Investments

Total Assets

Rs15.44 Billion

≈ $167.02 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2006–2025)

This chart shows how Ind-Swift Laboratories Limited's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see INDSWFTLAB total asset value.

Liquid Assets Composition Over Time

This chart breaks down Ind-Swift Laboratories Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore Ind-Swift Laboratories Limited long-term investment allocation to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Rs4.00 Billion	25.89%
Short-term Investments	Rs335.31 Million	2.17%
Total Liquid Assets	Rs4.33 Billion	28.07%

Asset Resilience Insights

Very High Liquidity: Ind-Swift Laboratories Limited maintains exceptional liquid asset reserves at 28.07% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Ind-Swift Laboratories Limited Industry Peers by Asset Resilience Ratio

Compare Ind-Swift Laboratories Limited's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Swedish Orphan Biovitrum AB (publ) ST:SOBI	Drug Manufacturers - Specialty & Generic	1.54%
Yunnan Baiyao Group Co Ltd SHE:000538	Drug Manufacturers - Specialty & Generic	8.38%
Guangdong Zhongsheng Pharmaceutical Co Ltd SHE:002317	Drug Manufacturers - Specialty & Generic	6.62%
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	Drug Manufacturers - Specialty & Generic	4.94%
Harbin Gloria Pharmaceuticals SHE:002437	Drug Manufacturers - Specialty & Generic	9.04%
Jiuzhitang Co Ltd SHE:000989	Drug Manufacturers - Specialty & Generic	7.86%
Renhe Pharmacy Co Ltd SHE:000650	Drug Manufacturers - Specialty & Generic	37.54%
Jiangsu Kanion Pharmaceutical Co Ltd SHG:600557	Drug Manufacturers - Specialty & Generic	0.29%

Annual Asset Resilience Ratio for Ind-Swift Laboratories Limited (2006–2025)

The table below shows the annual Asset Resilience Ratio data for Ind-Swift Laboratories Limited.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-03-31	2.74%	Rs393.66 Million ≈ $4.26 Million	Rs14.38 Billion ≈ $155.55 Million	+2.55pp
2024-03-31	0.19%	Rs27.87 Million ≈ $301.43K	Rs14.60 Billion ≈ $157.94 Million	-0.08pp
2023-03-31	0.27%	Rs49.55 Million ≈ $535.81K	Rs18.24 Billion ≈ $197.27 Million	-0.39pp
2022-03-31	0.66%	Rs118.90 Million ≈ $1.29 Million	Rs18.01 Billion ≈ $194.75 Million	+0.20pp
2021-03-31	0.46%	Rs83.02 Million ≈ $897.84K	Rs18.18 Billion ≈ $196.66 Million	-0.15pp
2020-03-31	0.60%	Rs112.72 Million ≈ $1.22 Million	Rs18.70 Billion ≈ $202.23 Million	-0.33pp
2019-03-31	0.93%	Rs178.74 Million ≈ $1.93 Million	Rs19.24 Billion ≈ $208.07 Million	+1.16pp
2018-03-31	-0.24%	Rs-47.69 Million ≈ $-515.75K	Rs20.23 Billion ≈ $218.78 Million	-1.61pp
2017-03-31	1.37%	Rs293.79 Million ≈ $3.18 Million	Rs21.38 Billion ≈ $231.16 Million	+1.38pp
2015-03-31	-0.01%	Rs-2.15 Million ≈ $-23.21K	Rs22.44 Billion ≈ $242.66 Million	-0.01pp
2013-03-31	0.00%	Rs1.00 Million ≈ $10.81K	Rs23.74 Billion ≈ $256.75 Million	-0.09pp
2012-03-31	0.10%	Rs21.00 Million ≈ $227.11K	Rs22.05 Billion ≈ $238.49 Million	-1.64pp
2011-03-31	1.73%	Rs301.00 Million ≈ $3.26 Million	Rs17.39 Billion ≈ $188.03 Million	+0.34pp
2006-03-31	1.39%	Rs71.60 Million ≈ $774.31K	Rs5.14 Billion ≈ $55.60 Million	--

pp = percentage points

About Ind-Swift Laboratories Limited

NSE:INDSWFTLAB India Drug Manufacturers - Specialty & Generic

Market Cap

$350.52 Million

Rs32.41 Billion INR

Market Cap Rank

#14207 Global

#703 in India

Share Price

Rs373.25

Change (1 day)

-1.32%

52-Week Range

Rs88.15 - Rs388.55

All Time High

Rs388.55